Search research articles
Contact Us
Filters
Showing results (521-530 of 623) with videos related to
Page
of 63
Sort By:
Journal of Clinical Psychopharmacology
|
August 16, 2003
A Canadian multicenter trial assessing memory and executive functions in patients with schizophrenia spectrum disorders treated with olanzapine
Emmanuel Stip, Gary J Remington, Serdar M Dursun, et al.
The Journal of Hospital Infection
|
August 12, 2018
Barriers and enablers to meticillin-resistant Staphylococcus aureus admission screening in hospitals: a mixed-methods study
K Currie, C King, K McAloney-Kocaman, et al.
Sarcoma
|
November 27, 2018
SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy
Edwin Choy, Karla Ballman, James Chen, et al.
Nature Communications
|
September 1, 2017
ATRX is a regulator of therapy induced senescence in human cells
Marta Kovatcheva, Will Liao, Mary E Klein, et al.
Parasitology Research
|
May 14, 2016
Antiplasmodial activity of selected medicinal plants used to treat malaria in Ghana
Gustav Komlaga, Sandrine Cojean, Rita A Dickson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 18, 2012
Phase II study of the HSP90-inhibitor BIIB021 in gastrointestinal stromal tumors
M A Dickson, S H Okuno, M L Keohan, et al.
Sarcoma
|
September 20, 2019
Corrigendum to "SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy"
Edwin Choy, Karla Ballman, James Chen, et al.
Molecular and Cellular Biology
|
January 29, 2000
Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics
M A Dickson, W C Hahn, Y Ino, et al.
Health Bulletin
|
November 1, 1976
The recording of prognostic factors in cerebrovascular disease
C Haslett, P Baird, N Chestnutt, et al.
The American Journal of Surgical Pathology
|
February 5, 2015
Dichotomy of Genetic Abnormalities in PEComas With Therapeutic Implications
Narasimhan P Agaram, Yun-Shao Sung, Lei Zhang, et al.
Page
of 63
Search research articles
Search
Showing results (521-530 of 623) with videos related to
Sort By:
Page
of 63
Journal of Clinical Psychopharmacology
|
August 16, 2003
A Canadian multicenter trial assessing memory and executive functions in patients with schizophrenia spectrum disorders treated with olanzapine
Emmanuel Stip, Gary J Remington, Serdar M Dursun, et al.
The Journal of Hospital Infection
|
August 12, 2018
Barriers and enablers to meticillin-resistant Staphylococcus aureus admission screening in hospitals: a mixed-methods study
K Currie, C King, K McAloney-Kocaman, et al.
Sarcoma
|
November 27, 2018
SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy
Edwin Choy, Karla Ballman, James Chen, et al.
Nature Communications
|
September 1, 2017
ATRX is a regulator of therapy induced senescence in human cells
Marta Kovatcheva, Will Liao, Mary E Klein, et al.
Parasitology Research
|
May 14, 2016
Antiplasmodial activity of selected medicinal plants used to treat malaria in Ghana
Gustav Komlaga, Sandrine Cojean, Rita A Dickson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 18, 2012
Phase II study of the HSP90-inhibitor BIIB021 in gastrointestinal stromal tumors
M A Dickson, S H Okuno, M L Keohan, et al.
Sarcoma
|
September 20, 2019
Corrigendum to "SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy"
Edwin Choy, Karla Ballman, James Chen, et al.
Molecular and Cellular Biology
|
January 29, 2000
Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics
M A Dickson, W C Hahn, Y Ino, et al.
Health Bulletin
|
November 1, 1976
The recording of prognostic factors in cerebrovascular disease
C Haslett, P Baird, N Chestnutt, et al.
The American Journal of Surgical Pathology
|
February 5, 2015
Dichotomy of Genetic Abnormalities in PEComas With Therapeutic Implications
Narasimhan P Agaram, Yun-Shao Sung, Lei Zhang, et al.
Page
of 63